Business Context and Reporting Period
This Form 6-K filing by Lloyds Banking Group plc, dated August 21, 2013, announces the signing of an agreement to sell its German life insurance business, Heidelberger Lebensversicherung AG ("Heidelberger Leben"), to a joint venture owned by Cinven Partners LLP and Hannover Rück SE.
Key Financial Metrics
- Sale Consideration: Approximately €300 million (approx. £250 million at current exchange rates).
- Gross Assets: £7.2 billion (predominantly policyholder assets).
- Historical Performance: Heidelberger Leben reported a statutory loss of £38 million for the year ended December 31, 2012.
- Expected Loss on Disposal: Approximately £330 million in the Group's accounts.
- Capital Impact: Expected benefit to Common Equity Tier 1 (CET1) capital of approximately £0.4 billion (approx. 13 basis points on a pro forma fully loaded CRD IV basis) when combined with other asset sales.
Material Changes and Transaction Details
The transaction represents a strategic move to rationalize the Group's international presence. Upon completion, senior management will transfer to the buyer, and the business will continue to service existing Group policies in Germany and Austria under the Clerical Medical brand via a long-term administration agreement. The cash proceeds are designated for general corporate purposes.
Outlook, Risks, and Contingencies
- Completion Timeline: Expected in early 2014, subject to regulatory approval.
- Forward-Looking Risks: The filing highlights risks including global economic conditions, Eurozone instability, sovereign credit rating downgrades, changes in regulatory capital requirements, and the ability to access sufficient funding.
- Strategic Alignment: The sale aligns with the Group's strategy to ensure value for shareholders and fulfill EC state aid obligations regarding asset disposals.
Investor Verification Checklist
- Confirmation of regulatory approval status for the transaction.
- Final exchange rate impact on the £250 million consideration at closing.
- Details of the long-term administration agreement for Clerical Medical policies.
- Actual CET1 capital benefit realization upon completion of this and other asset sales.
- Timeline for the expected early 2014 completion date.